Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series

Drug and Alcohol Review

Volumn 34, Issue 3, 2015, Pages 304-311

  Nielsen, Suzanne ^a,b,c   Murnion, Bridin ^b   Dunlop, Adrian ^d,e   Degenhardt, Louisa ^a,f,g,h   Demirkol, Apo ^c,i   Muhleisen, Peter ^d   Lintzeris, Nicholas ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^d Drug Alcohol Clinical Services   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Codeine; Dependence; Morphine; Oxycodone; Treatment

Indexed keywords

CODEINE; METHADONE; MORPHINE; OXYCODONE;

ADULT; FEMALE; HUMAN; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ATTITUDE; RETROSPECTIVE STUDY;

ADULT; CODEINE; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MORPHINE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; OXYCODONE; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84928726820     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12224     Document Type: Article

References (41)

1. Degenhardt L, Larance B, Mathers B, etal. Benefits and risks of pharmaceutical opioids: essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV. World Health Organisation. 2007.
2. Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011;30:264-270.
3. Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician 2012;15(3 Suppl.) :ES191-203.
4. Lipman AG, Jackson KC. Controlled prescription drug abuse at epidemic level. J Pain Palliat Care Pharmacother 2006;20:61-64.
5. Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011;195:280-284.
6. Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend 2004;73:199-207.
7. Miller NS, Greenfeld A. Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone. Am J Ther 2004;11:26-32.
8. Moore BA, Fiellin DA, Barry DT, etal. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med 2007;22:527-530.
9. Rosenblum A, Parrino M, Schnoll SH, etal. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007;90:64-71.
10. Wu LT, Woody GE, Yang C, Mannelli P, Blazer DG. Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Subst Abuse Rehabil 2011;2011:77-88.
11. Wu LT, Woody GE, Yang C, Blazer DG. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Addict Med 2011;5:28-35.
12. Martins SS, Storr CL, Zhu H, Chilcoat HD. Correlates of extramedical use of OxyContin® versus other analgesic opioids among the US general population. Drug Alcohol Depend 2009;99:58-67.
13. Sees KL, Di Marino ME, Ruediger NK, Sweeney CT, Shiffman S. Non-medical use of OxyContin Tablets in the United States. J Pain Palliat Care Pharmacother 2005;19:13-23.
14. Dutch MJ. Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Med J Aust 2008;188:56-57.
15. Frei M, Nielsen S, Tobin C, Dobbin M. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust 2010;193:294-296.
16. McDonough MA. Misuse of codeine-containing combination analgesics (Letter). Med J Aust 2011;194:486. P.
17. Australian Government DoHaA. National drugs and poisons schedule committee record of reasons. 2009 17-18 February 2009.
18. Chetty R, Baoku Y, Mildner R, etal. Severe hypokalaemia and weakness due to Nurofen(R) misuse. Ann Clin Biochem 2003;40:422-423.
19. Ernest D, Chia M, Corallo CE. Profound hypokalaemia due to Nurofen Plus and Red Bull misuse. Crit Care Resusc 2010;12:109-110.
20. Larson AM, Polson J, Fontana RJ, etal. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005;42:1364-1372.
21. Lee WM. The case for limiting acetaminophen-related deaths: smaller doses and unbundling the opioid-acetaminophen compounds. Clin Pharmacol Ther 2010;88:289-292.
22. Nielsen S, Cameron J, Lee N. Characteristics of a non-treatment seeking sample of over-the-counter codeine users: Implications for intervention and prevention. J Opioid Manag 2011;7:363-370.
23. Ross J, Teesson M, Darke S, etal. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev 2005;24:411-418.
24. Myers B, Siegfried N, Parry CD. Over-the-counter and prescription medicine misuse in Cape Town-findings from specialist treatment centres. S Afr Med J 2003;93:367-370.
25. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65-76.
26. Australian Institute of Health and Welfare. Alcohol and other drug treatment services national minimum data set 2012-13: specifications and collection manual. Drug Treatment Series number 17. Cat. no. HSE 123. Canberra: AIHW. 2012.
27. Nielsen S, Degenhardt L, Hoban B, Gisev N Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research. Technical Report No. 329. Sydney: National Drug and Alcohol Research Centre, University of New South Wales; 2014.
28. Pilgrim JL, Dobbin M, Drummer OH. Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. Med J Aust 2013;199:329-331.
29. Sigmon SC. Characterizing the emerging population of prescription opioid abusers. Am J Addict 2006;15:208-212.
30. Weiss RD, Potter JS, Fiellin D, etal. A two-phase randomized controlled trial of adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence. Arch Gen Psychiatry 2011;68:1238-1246.
31. Sigmon SC, Dunn KE, Badger GJ, Heil SH, Higgins ST. Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addict Behav 2009;34:304-311.
32. National AIHW. Opioid pharmacotherapy statistics annual data collection 2012. Canberra: HSE. 136; 2013.
33. Shah S, Diwan S. Methadone: does stigma play a role as a barrier to treatment of chronic pain? Pain Physician 2010;13:289-293.
34. Earnshaw V, Smith L, Copenhaver M. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addiction 2013;11:110-122.
35. Gowing L, Ali R, Dunlop A, Farrell M, Lintzeris N National guidelines for medication-assisted treatment of opioid dependence. 2014.
36. Sullivan LE, Fiellin DA. Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann Intern Med 2008;148:662-670.
37. Torrington M, Domier CP, Hillhouse M, Ling W. Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting. J Addict Dis 2007;26:93-99.
38. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005;6:107-112.
39. Passik SD, Kirsh KL. The interface between pain and drug abuse and the evolution of strategies to optimize pain management while minimizing drug abuse. Exp Clin Psychopharmacol 2008;16:400-404.
40. Martell BA, O'Connor PG, Kerns RD, etal. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146:116-127.
41. Nielsen S, Tobin C, Dobbin M. Over the counter codeine: Examining the evidence for and against. Australian Pharmacist 2012;31:236-240.